If combining NFTs with the medical industry doesn’t seem to make the most sense, this report from BuzzFeed News will probably confirm your skepticism. An NFT project called MetaDocs assigns doctors/influencers, like Dr. Pimple Popper, (somewhat unsightly) cartoon impersonations of themselves, which users can then purchase to access one-on-one conversations , Q&A sessions, or DMs.
But despite MetaDocs’ goal of cut the “bureaucracy” that comes with access to doctors, the MetaDocs themselves are not legally able to give medical advice to NFT holders. Like BuzzFeed points out, MetaDocs is not licensed to practice telemedicine, preventing its doctors from giving medical advice, writing prescriptions or diagnosing patients virtually.
“At this point, we are hesitant to designate anyone as a patient,” MetaDocs physician and dermatologist Dr. Dustin Portela said in a statement to BuzzFeed.
This disconnect is made even more evident with the price of one of these NFTs. According to BuzzFeedMetaDocs hasn’t determined a final price, but did throw in a cost of 0.2 ETH, or $570, in a recent white paper — an amount potentially higher than what you’d pay seeing a real GP without insurance ( depending on your location and the office, of course).
However, MetaDocs founder Dr. Sina Joorabachi said BuzzFeed that the value of MetaDocs NFTs is unrelated to medical care: “Our deliverable is to connect people with these physicians for a value of whatever they want to talk about or connect with.” The blurred lines between talking about medicine and medical advice may have caused some doctors to jump ship – BuzzFeed reports that nine physicians, including two who say they never consented to have their names included in the project, have since been removed from MetaDocs documentation.
In the future, MetaDocs hopes to revolutionize medical care, including examining patients wearing haptic suits in virtual reality. It may seem far, but not for MetaDocs. If you want to get a deeper insight into all this craziness, definitely go read BuzzFeed News‘ report.